Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Market Cap	31.93B
Revenue (ttm)	13.93B
Net Income (ttm)	2.20B
Shares Out	4.56B
EPS (ttm)	0.48
PE Ratio	14.62
Forward PE	12.71
Dividend	0.24 (3.49%)
Ex-Dividend Date	Jun 2, 2025

Volume	3,543,947
Average Volume	14,111,426
Open	7.15
Previous Close	7.00
Day's Range	6.87 - 7.15
52-Week Range	3.87 - 7.39
Beta	0.37
RSI	58.03
Earnings Date	Aug 28, 2025

About HKG:1066

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company’s medical device products include safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; and ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1988
• Employees: 12,719
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1066

Financial Performance

In 2024, HKG:1066's revenue was 13.09 billion, a decrease of -1.08% compared to the previous year's 13.23 billion. Earnings were 2.07 billion, an increase of 3.24%.

Financial numbers in CNY